UNDIFFERENTIATED SARCOMA
Clinical trials for UNDIFFERENTIATED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED SARCOMA trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug targets rare childhood cancers in new trial
Disease control Recruiting nowThis study tests a drug called lurbinectedin in people aged 10 and older whose solid tumors (like Ewing sarcoma) have returned after standard treatment. The goal is to see if the drug is safe and can shrink tumors or delay their growth. Participants must have a specific genetic c…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells take on sarcoma in new combo trial
Disease control Recruiting nowThis study tests whether a new type of immune cell therapy (HER2-CAR T cells) combined with drugs that boost the immune system (pembrolizumab or nivolumab) is safe for people with advanced sarcoma. About 25 participants will receive chemotherapy before the cell infusion to help t…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for sarcoma patients: immunotherapy plus chemo shows promise
Disease control Recruiting nowThis study tests a new combination of drugs (tislelizumab, liposomal doxorubicin, and ifosfamide) as a first treatment for people with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The goal is to see if this combo shrinks tumors and is safe. About …
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug shows promise for rare bone and soft tissue cancers
Disease control Recruiting nowThis study tests a new drug called QL1706 in 45 adults with advanced bone or soft tissue sarcoma that cannot be removed by surgery or has spread. Participants receive the drug every 3 weeks. The main goal is to see if the cancer stays stable for at least 12 weeks. Researchers wil…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for kids with tough cancers: GAIA-102 trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called GAIA-102 in children whose neuroblastoma or other solid tumors have not responded to standard treatments. The study has four groups, testing GAIA-102 alone or combined with other cancer drugs. The main goal is to check safety and fin…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC